Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00180479
Show Display Options
RSS Create an RSS feed from your search for:
NCT00180479
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)
Conditions: Stents;   Coronary Artery Disease;   Total Coronary Occlusion;   Coronary Artery Restenosis;   Stent Thrombosis;   Vascular Disease;   Myocardial Ischemia;   Coronary Artery Stenosis
Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent;   Device: TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent

Indicates status has not been verified in more than two years